Trafficking and recruitment of immune cells to the site of inflammation with spatial and temporal synchronization is crucial for the development of allergic airway inflammation. Particularly, chemokines are known to be key players in these processes. Previous studies revealed that the CXCL12/ CXCR4 axis plays an important role in regulating allergic airway inflammation. However, the role of CXCR7, a recently discovered second receptor for CXCL12, in regulating airway inflammation has not been explored. Initially, CXCR7 was considered as a decoy receptor; however, numerous subsequent studies revealed that engagement of CXCR7 triggered its own signalling or modulated CXCR4-mediated signalling. In the present study, we detected the expression of CXCR7 in airway epithelial cells. Use of a lentiviral delivery system to knock down the expression of CXCR7 in the lung of sensitized mice abrogated the cardinal features of asthma, indicating that CXCR7 plays a role in regulating allergic airway inflammation. The activation of mitogen-activated protein kinase and Akt signalling in response to CXCL12 in the mouse epithelial cell line MLE-12 was reduced when CXCR7 expression was knocked down. However, either knockdown or overexpression of CXCR7 in MLE-12 did not affect CXCL12-mediated calcium influx, indicating that CXCR7 does not modulate CXCR4-mediated signalling, and that it functions as a signalling receptor rather than a decoy receptor. Finally, we found that the expression of chemokine CCL2 is regulated by CXCR7/CXCL12-mediated signalling through b-arrestin in airway epithelial cells. Hence, regulating the expression of CCL2 in airway epithelial cells may be one mechanism by which CXCR7 participates in regulating allergic airway inflammation.
Introduction
Allergic airway inflammation is a disorder in which sensitized individuals develop eosinophilic airway inflammation, mucus hyper-secretion and airway hyperresponsiveness in response to inhaled aeroallergens. These features are orchestrated by dendritic cells, T helper type 2 (Th2) cells, eosinophils, mast cells and airway structure cells, such as epithelial cells. Trafficking and recruitment of leucocytes with spatial and temporal synchronization are important for establishing allergic airway inflammation. Chemokines, small chemotactic proteins, are key players in these processes and allow leucocytes with a corresponding receptor to migrate from the bloodstream into interstitial spaces and contribute to the inflammation process.
CXCL12, also known as stromal-derived factor-1, was originally identified as a pre-B-cell growth factor. 1 Despite its roles in haematopoiesis and inflammation, CXCL12 also has important functions in various biological processes, including cardiac and neuronal development, 
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stem cell motility, neovascularization, angiogenesis, apoptosis, tumorigenesis and metastasis. [2] [3] [4] [5] [6] CXCR4 has long been thought to be the only receptor for CXCL12, as CXCR4-deficient and CXCL12-deficient mice have similar phenotypes. 7, 8 Evidence from human and animal studies revealed that CXCL12/CXCR4 plays an important role in allergic airway inflammation. [9] [10] [11] [12] Using a CXCR4 or CXCL12 neutralization antibody or the CXCR4 antagonist AMD3100, the CXCL12/CXCR4 axis has been demonstrated to play a pivotal role in airway inflammation and airway hyper-responsiveness in an allergic airway-inflammation mouse model. 9, 10 Indeed, in patients with asthma, a high concentration of CXCL12 was observed in the bronchoalveolar lavage fluid (BALF), and levels of the chemokine were correlated with the number of leucocytes, including lymphocytes, macrophages and eosinophils, indicating that CXCL12 contributes to their recruitment into the airway. 11 Recently, the orphan receptor RDC-1, now known as CXCR7, was demonstrated to be an additional receptor for CXCL12. 13, 14 Its binding affinity to CXCL12 is fivefold to tenfold higher than that of CXCR4 to CXCL12. 13, 15 It is well accepted that CXCR7 is an atypical chemokine receptor, as engagement of CXCR7 does not trigger typical chemokine receptor signalling, such as calcium mobilization and chemotaxis. 14, 16 Therefore, CXCR7 has been suggested to function as a decoy receptor that sequesters/scavenges CXCL12 from the environment, thereby shaping the availability of the chemokine for the signalling receptor CXCR4. [17] [18] [19] [20] [21] However, studies of different cells and pathophysiological conditions have revealed a broad range of CXCR7 functions, showing that CXCL12 engagement to CXCR7 can induce a range of cellular responses, such as activation of the mitogenactivated protein kinase (MAPK) and Akt pathways, 22 receptor internalization, 13, 17 cell survival, 14, [22] [23] [24] proliferation 25 and adhesion. 22, 23, 26 Indeed, overexpression studies showed that when heterodimerized with CXCR4, CXCR7 can influence CXCR4-dependent G protein-mediated cell signalling, therefore affecting the role of CXCR4 in cellular physiology. 16, [26] [27] [28] Recently, other studies showed that b-arrestin-2, other than G protein-mediated signalling, is triggered by the engagement of CXCR7. 27, [29] [30] [31] As the second and newly identified receptor for CXCL12, the role of CXCR7 in allergic airway inflammation has not been evaluated. In the present study, we examined whether CXCR7 is involved in regulating allergic airway inflammation. Our results suggest that epithelial CXCR7 may be involved in regulating the cardinal features of asthma by functioning as a signalling receptor rather than a decoy receptor, without affecting CXCR4-mediated signalling. One of the possible mechanisms by which epithelial CXCR7 regulates allergic airway inflammation is through regulating the expression of CCL2 during inflammation.
Materials and methods

Animals and cells
Female BALB/c mice (6-8 weeks old) were purchased from the National Laboratory Animal Centre of Taiwan. All experiments conducted in this study were in accordance with the Institutional Animal Care and Use Committee of China Medical University according to Care of the Animals and Surgical Procedures of China Medical University Protocols (Approval protocol number: 102-183-N). MLE-12, a mouse respiratory epithelial cell line obtained from ATCC (Manassas, VA), was cultured in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum.
Immunofluorescence staining of CXCR7 and CXCR4
Lungs were inflated with a mixture of 1 : 1 OCT/PBS and snap-frozen in optimum cutting temperature (OCT) on dry ice. Frozen sections (10 lm) were prepared, fixed with cold acetone for 3 min, dried and washed. The tissue sections were blocked using 1% bovine serum albumin inPBS containing 0Á05% Tween-20 and stained with CXCR7 (11G8) (R&D Systems, Minneapolis, MN) or CXCR4 (H-118) (Santa Cruz Biotechnology, Dallas, TX) antibodies. The tissue sections were then incubated with secondary antibodies, Alexa Fluor 488-conjugated chicken anti-rabbit IgG and Alexa Fluor 594-conjugated chicken anti-rabbit IgG (Thermo Fisher Scientific, Waltham, MA), respectively. Nuclei were counterstained with DAPI (Sigma-Aldrich, St Louis, MO). Protein expression was observed using a fluorescence microscope ECLIPSE 80i (Nikon Instruments, Inc., Tokyo, Japan).
Murine model of allergic airway inflammation
The protocol has been described previously. 32 Briefly, the scheme of animal sensitization, treatment and challenge is shown in Fig. 1 . Cytospin preparations from BALF, obtained by flushing the lungs with PBS, were stained with Pappenheim stain for cell differential analysis. Serum obtained by cardiac puncture was used to measure ovalbumin (OVA) -specific IgE. Cells from mediastinal lymph nodes were prepared for the T-cell re-stimulation assay. 32 The concentrations of cytokines in culture supernatants after 48 hr of culture were measured using a Duo Set ELISA kit (R&D Systems). Whole lung lobes were dissected for histological and biochemical analyses.
Western blot analysis
Total cellular protein was prepared by lysing cells with SDS sample buffer. The proteins were separated on a 10% SDS-polyacrylamide gel and transferred onto a polyvinylidene fluoride membrane. Membranes were blocked with PBS containing 5% bovine serum albumin and incubated with the indicated antibodies. The blots were further incubated with the appropriate horseradish peroxidase-conjugated secondary antibodies and developed using an enhanced chemiluminescence detection system (PerkinElmer, Waltham, MA) according to the manufacturer's instructions. The intensity of each band was quantified and analysed using IMAGE J software (National Institutes of Health, Bethesda, MD).
Lentivirus preparation and stable silencing of target genes
Lentivirus bearing target gene short hairpin RNA (shRNA) was prepared according to the protocols provided by the National Core Facility for Manipulation of Gene Function by RNAi, miRNA, miRNA sponges and CRISPR/Genomic Research Centre at Academia Sinica in Taiwan.
The target sequences for mouse CXCR7 were: shRNA#1:
The target sequences for mouse b-arrestin-2 were:
MLE-12 cells (5 9 10 5 ) were transfected with lentiviral expression vector containing shRNA in six-well culture plates and selected in medium containing 0Á75 lg/ml puromycin 1 day later for stable silencing of the target gene.
Calcium mobilization assay
Calcium mobilization responses were measured using Fluo3 according to the manufacturer's instructions (Invitrogen, Carlsbad, CA). MLE-12 wild-type cells were loaded with 10 nM/ml Fluo3 and 0Á02% F127 for 30 min at 37°in a 5% CO 2 incubator. The cells were then treated with or without 250 ng/ml CXCL-12 (R&D Systems). Fluo-3 was excited at 488 nm and emitted fluorescence was measured with a 515-nm long-pass filter. The relative fluorescence unit of calcium binding was measured using a Synergy H1 Hybrid Multi-Mode Microplate Reader (BioTek, Winooski, VT).
Statistical analysis
The results were compared using one-way analysis of variance (ANOVA) with the software program GRAPHPAD PRISM 5 (GraphPad, Inc., La Jolla, CA). The data are presented as the mean AE standard error of mean (SEM). Probability values (P) of < 0Á05 were considered statistically significant.
Results
Identification of CXCR7 expression in airway epithelial cells
To examine whether CXCR7 is expressed in the lung, Western blotting analysis was performed using the protein prepared from lungs of naive mice or allergeninduced airway-inflamed mice. As shown in Fig. 2(a) , the expression of CXCR7 was increased in the lungs of inflamed mice. Furthermore, immunofluorescence staining of lung tissue from inflamed mice indicated that CXCR7 was predominantly expressed in epithelial cells. In contrast to CXCR4, which was expressed in airway epithelial cells, the expression of CXCR7 could be further detected in vessel endothelial cells (Fig. 2b) .
Knockdown of CXCR7 in the lung reduced allergic airway inflammation
Because CXCR7 knockout mice show early postnatal lethality, 16, 33 to examine whether CXCR7 plays a role in regulating Th2-mediated allergic airway inflammation, we carried out an experiment using a murine asthma model in which CXCR7 was knocked-down by intratracheally delivering lentivirus carrying CXCR7 shRNA into sensitized mice before challenge ( Fig. 1) . To investigate the effect of CXCR7 on airway inflammation, total and differential cell counts in BALF were analysed after the mice were challenged with the allergen OVA. The relative expression levels of CXCR7 in the lung of challenged mice are shown in the Supplementary material (Fig. S1 ). When CXCR7 expression was knocked down before challenge, less cell infiltration was observed in the lungs of challenged mice (Fig. 3a) . Histological examination of fixed lung tissue prepared from these mice revealed that the extent of peribronchiolar cell inflammation and mucus secretion was lower in mice that received lentivirus carrying CXCR7 shRNA than in mice that received lentivirus carrying the control vector alone (Fig. 3b) .
Knockdown of CXCR7 in the lung reduced serum allergen-specific IgE production and T-cell cytokine production Elevated levels of IgE in patients with asthma are also an indicator of allergy. Therefore, we examined whether knockdown of CXCR7 in the lung could reduce the level of OVA-specific IgE in the serum. We found that OVA-specific IgE levels were significantly reduced (Fig. 4a) . Th2 cells play a central role in the disease process, contributing to IgE production by B cells, growth and differentiation of eosinophils and mast cells, and the development of bronchial hyperactivity and goblet cell hyperplasia. Hence, to further establish whether the T-cell response was defective, cytokine production by mediastinal lymph node cells isolated from mice following restimulation with antigen-presenting cells and OVA were analysed by ELISA. As shown in Fig. 4(b) and the Supplementary material (Fig. S2 ), Th2-related cytokine production was diminished when CXCR7 expression was knocked down in the lung. Because CXCR7 was knockeddown after sensitization, the function and numbers of existing effector and memory T cells were the same as in the control, indicating that the re-activation/expansion of effector/memory cells was defective during challenge when CXCR7 expression was knocked down. Development of airway hyper-responsiveness was reduced when CXCR7 was knocked down in the lung
We subsequently examined whether knockdown of CXCR7 expression in the lung suppressed the development of airway hyper-responsiveness. As shown in Fig. 5 , CXCR7-knockdown mice showed significant decreases in pulmonary resistance compared with the control.
CXCR7 functions as a signalling receptor rather than a decoy receptor in lung epithelial cells
Depending on the cell type, tissue and pathophysiological state, CXCR7 can function as a decoy receptor or signalling receptor. As shown in Fig. 2(b) , both CXCR7 and CXCR4 were expressed in airway epithelial cells; so it is unlikely that CXCR7 functions as a decoy receptor that ) in lung section (n = 3). Numbers for PAS staining represent the mean AE SEM of H-Score (n = 3). **P < 0Á01; ***P < 0Á001 compared with Lenti-Control. Statistical significance was determined by one-way ANOVA. NC: negative control, mice sensitized and challenged with PBS. PC: positive control, mice sensitized and challenged with OVA. Lenti-Control: lentivirus carrying control vector was intratracheally administered to sensitized mice 2 weeks before challenge. Lenti-CXCR7 shRNA: lentivirus carrying CXCR7 short hairpin RNA was intratracheally administered to sensitized mice 2 weeks before challenge. sequesters CXCR12 from the environment to shape the availability for the signalling receptor CXCR4. As we delivered lentivirus carrying CXCR7 shRNA into mice intratracheally, the cell types infected were predominantly epithelial cells. To confirm whether engagement of CXCR7 participates in CXCL-12-mediated lung epithelial signalling, MLE-12 cells, a mouse lung epithelial cell line, and their derived control (bearing control vector), as well as a CXCR7-knockdown cell line (bearing CXCR7 shRNA expression construct) were stimulated with CXCL12, after which the activation of MAPK (ERK, JNK, and P38) and Akt was analysed. Knockdown efficacy is shown in the Supplementary material (Fig. S3) . Although CXCL12 activated MAPK and Akt signalling in wild-type and control MLE-12 cells, the knockdown of CXCR7 attenuated the intensity of the CXCL12-MAPK and CXCL12-Akt signals (Fig. 6a and the Supplementary material, Fig. S4 ), indicating that CXCR7 participates in CXCL-12-mediated signalling.
Although the engagement of CXCR7 does not trigger typical G protein coupled receptor-dependent signalling, it has been proposed that CXCR7 might serve as a coreceptor for CXCR4 and influence CXCL12/CXCR4-mediated G-protein signalling. 16 Fig. S3) ; however, to clarify whether CXCR7 might influence CXCL12/ CXCR4-mediated G-protein signalling, calcium influx, a typical Gai-coupling-mediated signalling, induced by CXCL12 was examined. No significant difference was observed between wild-type airway epithelial cells and CXCR7-knockdown cells (Fig. 6b) or cells overexpressing CXCR7 (Fig. 6c) , indicating that engagement of CXCR7 by CXCL12 in airway epithelial cells triggers signalling and does not interfere with CXCR4/CXCL-12-mediated signalling.
CXCR7 signal elevates the expression levels of CCL2 in airway epithelial cells
To identify the potential mediators induced by CXCR7 engagement that participate in regulating allergic airway inflammation, a cytokine protein array was used to examine the cytokine profile in the BALF of challenged mice. We found that the concentration of monocyte chemotactic protein-1, also known as CCL2, was also reduced (Fig. 7a) . monocytes to the site of inflammation and plays an important role in asthmatic responses. [34] [35] [36] [37] To confirm that airway epithelial cells can produce CCL2 in response to CXCL-12, MLE-12 was stimulated with CXCL-12. As shown in Fig. 7(b) , CXCL-12 can induce airway epithelial cells to produce CCL2. To confirm that airway epithelial cells can produce CCL2 through the CXCL12/CXCR7-mediated pathway, MLE-12 was stimulated with CXCL-12. Indeed, when CXCR7 was overexpressed in airway epithelial cells, the production of CCL2 by these cells was augmented (Fig. 7c) . This indicates that CXCR7 could regulate the production of CCL2 in airway epithelial cells. To examine whether CXCL12/CXCR7-induced CCL2 expression bypasses the CXCL12/CXCR4-mediated signalling pathway, AMD3100, a CXCR4 antagonist was used. As shown in Fig. 7(b) , in response to CXCL12, the production of CCL2 was not altered when CXCR4-mediated signalling was blocked by AMD3100, indicating that CXCL12-induced expression of CCL2 is not through CXCR4. It is known that b-arrestin-2, other than G protein-mediated signalling, is triggered by the engagement of CXCR7. 27, [29] [30] [31] To examine whether CXCL12/CXCR7-induced CCL2 expression is through b-arrestin, b-arrestin was knocked down in MLE-12 cells and the production of CCL2 in response to CXCL12 was examined. As shown in Fig. 7(d) , the production of CCL2 was decreased when b-arrestin was knocked down in MLE-12 cells. These data indicate that CXCL12/CXCR7 induced CCL2 expression through b-arrestin, without bypassing the CXCL12/ CXCR4-mediated signalling pathway.
Discussion
Our data indicate that CXCR7 functions as a signalling receptor and is expressed in the airway epithelium. Its expression was further augmented under inflamed conditions. Engagement of CXCR7 is involved in regulating the cardinal features of asthma, as knockdown of CXCR7 in the lung of sensitized mice using a lentiviral delivery system abrogated the characteristic features of asthma, such as inflammation, mucus secretion, serum IgE concentration and airway hyper-responsiveness. We further found that these defective features may have resulted in part from lower production of CCL2 in the lung.
CCL2 (monocyte chemotactic protein/CCL2) is expressed by many different cell types, including epithelial cells. CCL2 is a potent chemoattractant not only for macrophages, but also for basophils and activated and memory T cells. [38] [39] [40] [41] Several studies have suggested that CCL2/CCR2 play important roles in the pathogenesis of asthma. 42 Elevated CCL2 levels are present in the BALF of individuals with asthma. 37 Significant release of CCL2 into the airway after endobronchial challenge has also been observed in patients with asthma. 36 Polymorphisms in the CCL2 gene are associated with asthma in children and adults. 43 When CCL2 activity was blocked with neutralization antibodies, the levels of airway inflammation and hyper-responsiveness were attenuated. 34, 35, 42 Additionally, in CCR2-deficient mice, airway hyper-responsiveness was significantly reduced. 34 Furthermore, CCL2 was also shown to influence T-cell differentiation towards Th2 cells and enhance T cells to produce interleukin-4. 44, 45 In this study, we observed defective recall T-cell responses in the lymph node (Fig. 4b and Supplementary  material, Fig. S1 ). Because CXCR7 was knocked-down before challenge, the function and numbers of existing effector and memory T cells before challenge were expected to be the same between control and experimental groups. It is likely that the re-activation/expansion of effector/memory cells was defective, resulting in a reduced number of effector T cells in the mediastinal lymph nodes, and so fewer activated effector T cells in the lymph node were available for re-stimulation.
Dendritic cells (DCs) are known to be important in inducing T helper cell immunity in the lymph node. 46, 47 When CD11c + cells were conditionally depleted locally from the lung immediately before the antigen (OVA) challenge in OVA-sensitized mice, van Rijt LS et al. observed that in the absence of DCs, the cardinal features of asthma failed to develop and that ex vivo isolated CD4 T cells produced greatly diminished amounts of Th2-related cytokines, 46 indicating that DCs are key cells in Figure 5 . Reduced airway hyper-responsiveness following CXCR7 knockdown. Airway resistance was measured 48 hr after the final challenge by invasive body plethysmography. Data are expressed as the mean AE SEM of pulmonary resistance (R L ) (n = 3). **P < 0.01; ***P < 0Á001. Statistical significance was determined by one-way 47 Upon inhalation of an antigen, lung epithelial cells produce CCL2 and CCL7, which induce the release of CCR2 + monocytes from the bone marrow. When the monocytes reach the airway, they give rise to not only monocyte-derived macrophages, but also monocytederived DCs. Interestingly, we found that the concentrations of CCL2 in the BALF of CXCR7-knockdown inflamed mice were reduced, which may explain why we observed fewer macrophages in the BALF (Fig. 3a) . We further demonstrated that CCL2 expression was regulated by CXCL12/CXCR7-mediated signalling in lung epithelial cells. Epithelial cell-derived products clearly have the potential to modulate the lung microenvironment and DC functional maturation. Hence, one of the mechanisms by which CXCR7 regulates allergic airway inflammation may be through regulating the expression of epithelial cell-derived proteins such as CCL2, which may influence DC functional maturation or regulate the recruitment of monocytes. This subsequently gives rise to DCs, so increasing the number of antigen-bearing DCs migrating to the draining lymph node. It would be of interest to examine the function and number of DCs that migrate into mediastinal lymph nodes.
In conclusion, the present study demonstrated that expression of CXCR7 in the lung is up-regulated during inflamed conditions and that engagement of CXCR7 with CXCL12 triggers signal transduction and regulates gene expression. CCL2, an important mediator of allergic immune responses, is one of the molecules regulated by CXCR7-mediated signalling, implicating the critical role of CXCR7 in regulating allergic airway inflammation. Hence, CXCR7 could be a potential therapeutic target for allergic airway diseases. 
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